![]()
reuters | UPDATE 1-Drugmaker Teva does not see big impact on business from Israel-Hamas war |
morningstar | Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023 |
investors | Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. |
morningstar | Teva Announces Changes to Executive Management Team |
fool | 3 No-Brainer Stocks to Buy With $20 Right Now |
apnews | Teva to pay $225M to settle cholesterol drug price-fixing charges |
reuters | UPDATE 1-Teva to pay $225 mln to settle price-fixing charges |
wsj | Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges |
reuters | Teva agrees to pay $126 million to US hospitals over opioids |
reuters | Teva agrees to pay $126 mln to US hospitals over opioids |
businesswire | Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs |
reuters | UPDATE 1-Teva CEO says not too late to launch Humira biosimilar in 2024 |
fool | Teva Pharmaceutical Industries Q2 2023 Earnings Call Transcript |
investors | Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise |
businesswire | Teva Reports Second Quarter 2023 Financial Results |
businesswire | Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development |
morningstar | Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership |
markets.ft | Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023 |
duckduckgo | Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine |
barrons | Patients Can’t Get Some Lifesaving Drugs. What’s Causing the Shortages. |
insidermonkey | 11 Best Medical Stocks Under $10 |
fool | 3 Bargain Stocks to Buy on the Dip |
wsj | Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It |
morningstar | Teva Concludes Nationwide Opioids Settlement Agreement |
reuters | Teva to pay Nevada $193 million over role in opioid epidemic |
fool | Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? |
businesswire | Teva Presents Real-World Data for AUSTEDO® Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023 |
yahoo | Shareholders in Teva Pharmaceutical Industries have lost 66%, as stock drops 6.3% this past week |
